Closure of the ductus arteriosus - New insights for critical care

Critical Care Nursing Quarterly

Volumn 20, Issue 4, 1998, Pages 80-85

  Angerio, Allan D ^a   Kot, Peter A ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Carbon monoxide; Cytochrome P450; Ductus arteriosus; Endothelin; Nitric oxide; Prostaglandin E2

Indexed keywords

BETAMETHASONE; CARBON MONOXIDE; CYTOCHROME P450; DEXAMETHASONE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR AGONIST; GLUCOCORTICOID; INDOMETACIN; NITRIC OXIDE; OXYGEN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; VASOCONSTRICTOR AGENT;

DUCTUS ARTERIOSUS OBLITERATION; HUMAN; INTENSIVE CARE; NONHUMAN; OXYGEN TENSION; PATENT DUCTUS ARTERIOSUS; REVIEW; VASOCONSTRICTION;

EID: 0031975184     PISSN: 08879303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002727-199802000-00009     Document Type: Review

References (28)

1. Kennedy A, Clark SL. Observations of the ductus arteriosus of the guinea pig in relation to its method of closure. Anat Rec. 1941;79:349-363.
2. Kennedy JA, Clark SL. Observations on the physiological reactions of the ductus arteriosus. Am J Physiol. 1942;136:140-147.
3. Fay FS. Guinea pig ductus arteriosus. I. Cellular and metabolic basis for oxygen sensitivity. Am J Physiol. 1971;221(2):470-479.
4. Coceani F, Hamilton NC, Labuc J, Olley PM. Cytochrome P450 linked monooxygenase: involvement in the lamb ductus arteriosus. Am J Physiol. 1984;246: H640-H643.
5. Coceani F, Olley PM. The response of the ductus arteriosus to prostaglandins. Can J Physiol Pharmacol. 1973;51:220-225.
6. Sidens E, Yokochi K, Coceani F, Olley PM. Prostaglandins and fetal cardiac output distribution in the lamb. Am J Physiol. 1985;248:H853-H858.
7. 2 in prenatal patency of the lamb ductus arteriosus. Can J Physiol Pharmacol. 1986;64:737-744.
8. Starling MB, Elliott RB. The effects of prostaglandins, prostaglandin inhibitors, and oxygen on the closure of the ductus arteriosus, pulmonary arteries and umbilical vessels in vitro. Prostaglandins. 1974;8:187-203.
9. Coceani F, Breen CA, Lees JG, Falck JR, Olley PM. Further evidence implicating a cytochrome P450-mediated reaction in the contractile tension of the lamb ductus arteriosus. Circ Res. 1988;62:471-477.
10. Heymann MA, Rudolph AM. Control of the ductus arteriosus. Physiol Rev. 1975;55:62-78.
11. White RE, Coon MJ. Oxygen activation by cytochrome P450. Ann Rev Biochem. 1980;49:315-356.
12. 2 constriction? Can J Physiol Pharmacol. 1989;67:1448-1450.
13. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazald Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
14. Haegerstrand A, Hemsen A, Gillis C, Larsson O, Lundberg JM. Endothelin: presence in human umbilical vessels, high levels in fetal blood and potent vasoconstrictor effect. Acta Physiol Scand. 1989;137:541-542.
15. Coceani F, Armstrong C, Kelsey L. Endothelin in a potent constrictor of the lamb ductus arteriosus. Can J Physiol Pharmacol. 1989;67:902-904.
16. Coceani F, Kelsey L. Endothelin-1 release from the lamb ductus arteriosus: relevance to postnatal closure of the vessel. Can J Physiol Pharmacol. 1991;69:218-221.
17. Coceani F, Kelsey L, Seidlitz E. Evidence for an effector role of endothelin in closure of the ductus arteriosus at birth. Can J Physiol Pharmacol. 1992;70:1061-1064.
18. Coceani F, Kelsey L, Ackerley C, Rabinovitch M, Gelboin H. Cytochrome P450 during ontogenic development: occurrence in the ductus arteriosus and other tissues. Can J Physiol Pharmacol. 1994;72:217-226.
19. 2Physiol Pharmacol. 1986;64:737-744.
20. Coceani F, Kelsey L, Seidlitz E. Occurrence of endothelium-derived relaxing factor-nitric oxide in the lamb ductus arteriosus. Can J Physiol Pharmacol. 1994;72:82-88.
21. 2, and the nitric oxide donor, 3-morpholinosydnonimine, in lambs and their clinical applications. Br Heart J. 1995;73:177-181.
22. Coceani F. Control of the ductus arteriosus - a new function for cytochrome P450, endothelin and nitric oxide. J Biochem Pharmacol. 1994;48:1315-1318.
23. Weiss H, Cooper B, Brook M, Schlueter M, Clyman RC. Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin. J Pediatr. 1995;127:466-471.
24. Grosfeld JL, Chaet M, Molinari F, Engle W, Engum SA, West KW, Rescorla FJ, Scherer LR. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg. 1996;224:350-357.
25. Heyman E, Ohlsson A, Shenna AT, Heilbut M, Coceani F. Closure of the patent ductus arteriosus after treatment with dexamethasone. Acta Pediatr Scand. 1990;79:698-700.
26. Clyman RI, Ballard PL, Sniderman S, Ballard A, Roth R, Heymann MA, Granberg JP. Prenatal administration of beta methasone for prevention of patent ductus arteriosus. J Pediatr. 1981;98:123-126.
27. Clyman RI, Mauray F, Roman C, Rudolph AM, Heyman MA. Effects of antenatal glucocorticoid administration on the ductus arteriosus of preterm lambs. Am J Physiol. 1981;241:H415-H420.
28. Momma K, Takao A. Increased constriction of the ductus arteriosus with combined administration of indomethacin and betamethasone in fetal rats. Pediatr Res. 1989;25:69-75.